Two Cases of Severe Amanita Muscaria Poisoning Including a Fatality.
Ethan M Meisel, Brent Morgan, Michael Schwartz, Ziad Kazzi, Huseyin Cetin, Aynur Sahin
Wilderness & environmental medicine December 1, 2022 DOI: 10.1016/j.wem.2022.06.002 via PubMed
Summary
AI-generated from the abstractIngestion of Amanita muscaria mushrooms, which contain ibotenic acid and muscimol, can cause serious toxicity and even death, contrary to the traditional view that such ingestions are benign. Two cases illustrate this: a 44-year-old man died 9 days after ingesting 4 to 5 dried caps, and a 75-year-old man fully recovered after accidentally consuming one large cap. The neuroactive chemicals affect the brain, and certain high-risk features can predict more severe outcomes.
Study at a glance
| Characteristics | Case study Case report Peer reviewed |
|---|---|
| Sample size | 2 |
| Population | Patients who ingested Amanita muscaria mushrooms |
| Keywords | Ibotenic acid Muscimol Mushrooms Mycotoxins Toxicity |
| Key finding | Amanita muscaria ingestion can lead to serious outcomes including death, and is not always benign. |
Abstract
Ingestion of Amanita muscaria mushrooms results in transient central nervous system excitation and depression mediated by its components, ibotenic acid and muscimol. The mushroom is distributed worldwide and ingestions occur with some frequency. Although these ingestions have traditionally been considered benign, serious complications can occur. We present 2 cases of serious toxicity, including a fatality. The first case was a 44-y-old man who presented to the emergency department (ED) after cardiopulmonary arrest approximately 10 h after ingesting 4 to 5 dried A muscaria mushroom caps, which he used for their mind-altering effects. Despite successful resuscitation, he remained unresponsive and hypotensive and died 9 days later. The second case was a 75-y-old man who presented to the ED after accidentally consuming one large A muscaria mushroom cap he foraged in Eastern Turkey. The patient initially presented to the ED with hallucinations followed by lethargy, and he was intubated for airway protection. The patient's condition gradually improved, and he made a full recovery. A muscaria ingestion should not be considered benign as serious outcomes do occur. An understanding of how the main neuroactive chemicals, ibotenic acid and muscimol, affect the brain can help anticipate outcomes. Several high-risk features that portend a more serious course are identified.